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Abstract
Dentinogenesis imperfecta (DGI) type II is an autosomal dominant disease characterized by a serious disorders in teeth.
Mutations of dentin sialophosphoprotein (DSPP) gene were revealed to be the causation of DGI type II (DGI-II). In this study,
we identified a novel mutation (NG_011595.1:g.8662T.C, c.135+2T.C) lying in the splice donor site of intron 3 of DSPP
gene in a Chinese Han DGI-II pedigree. It was found in all affected subjects but not in unaffected ones or other unrelated
healthy controls. The function of the mutant DSPP gene, which was predicted online and subsequently confirmed by in vitro
splicing analysis, was the loss of splicing of intron 3, leading to the extended length of DSPP mRNA. For the first time, the
functional non-splicing of intron was revealed in a novel DSPP mutation and was considered as the causation of DGI-II. It
was also indicated that splicing was of key importance to the function of DSPP and this splice donor site might be a
sensitive mutation hot spot. Our findings combined with other reports would facilitate the genetic diagnosis of DGI-II, shed
light on its gene therapy and help to finally conquer human diseases.
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Introduction
Dentinogenesis imperfecta (DGI), a kind of hereditary dentin
defect, causes the teeth of the patients discolored, translucent and
even weaker than normal. It is classified into three types. DGI type
I (DGI-I) is syndromic and mainly found simultaneously with
osteogenesis imperfecta (OI). DGI type II (DGI-II) is more
common and inherited in an autosomal dominant manner.
Patients with DGI-II exhibit an opalescent hue of their discolored
and translucent teeth. The teeth could be shortened approaching
to the DEJ, even to the alveolar ridge. Narrow or even obliterated
pulp chamber and root canals were shown under X-ray. DGI type
III (DGI-III), which was first found in three isolated pedigrees in
the United States in 1957, is now considered as a more severe form
of DGI-II [1].
By linkage analysis and further sequence scan, the dentin
sialophosphoprotein (DSPP) gene was identified to be the key gene
associated with DGI, especially type II and type III [1]. DSPP
gene is located on chromosome 4q21.3 and encodes the major
noncollagenous protein in tooth dentin. Abundant insoluble
mutant DSPP and its degradation products (dentin phosphopro-
tein, DPP and dentin sialoprotein, DSP) expressed by odontoblast
cells could possibly be hypothesized to deactivate or indirectly
interfere with the metabolism of other proteins in dentin and result
in the phenotypes of DGI.
Mutations in the DSPP gene have been revealed and reported
to be the principal cause of DGI type II and type III [1–4]. They
could be in exons or introns, could affect one single peptide or
cause frameshift of the entire following sequence [5]. Most of these
mutations were just reported in DGI affected individuals by
sequence analysis, but not further functionally confirmed.
Functional confirmation of disease-causing or susceptible varia-
tions will definitely help in the understanding of the mechanism of
the causation or susceptibility and solidify the association.
Results and Discussion
We identified a pedigree with severe DGI-II in Shaanxi, China.
From the family tree spanning five generations (Figure 1), the
disease was shown to be inherited in an autosomal dominant
manner. The proband is a young man, IV12 in the family tree. He
was hospitalized because of dyspepsia. He presented with a
severely affected permanent dentition. His all incisor teeth and
four first molar teeth exhibited translucent and opalescent hue,
color in dark-yellow to amber. The enamel on the occlusal and
lingual surfaces was of serious wear. Dental crowns were shortened
and globose, approaching to the DEJ, even to the alveolar ridge
(Figure 2).
The regions containing exon2, exon3 and intron3 of DSPP gene
were sequenced to detect the causative mutation of this pedigree.
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(NG_011595.1:g.8662T.C, c.135+2T.C) was discovered in all
affected subjects, while in four unaffected individuals and other
105 unrelated healthy controls, this site was in wild type (Figure 3).
Online splicing prediction by SplicePort (http://spliceport.cs.
umd.edu) [6] showed that this mutation might change gene
splicing by missing the normal splice donor (location: 3660, short
sequence: tacaggtatagg, score: 0.938934), which might lead to the
loss of splicing of intron 3. As no DSPP transcript was able to be
detected in gingiva or peripheral blood sample by RT-PCR, we
decided to confirm the function of this causal mutation by in vitro
splicing analysis using the vector pLRT which contained the
splicing reporter LTR-SD1-SAExon-SD-SA5opt [7,8].
Both wild type and mutant DSPP alleles (1933bp containing
whole exon3-intron3-exon4 and partial intron 2 and intron 4)
Figure 1. The family tree of the pedigree. The arrow shows the proband IV12.
doi:10.1371/journal.pone.0027982.g001
Figure 2. Clinical manifestations of the proband IV12.
doi:10.1371/journal.pone.0027982.g002
Figure 3. Sequencing raw data of subjects V6 (an unaffected
member) and V8 (an affected member). The data are from the
reverse complementary sequencing with the primer DSPP_New3R. The
arrows show the complementary nucleotide of g.8662 site. V6 has
homozygous A while V8 has heterozygous A/G.
doi:10.1371/journal.pone.0027982.g003
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the recombinant plasmids. The plasmids together with naı ¨ve
pLRT were transfected into 293T cells. Twenty-four hours after
the transfection, total RNAs were extracted and reverse tran-
scribed to cDNAs. By PCR and subsequent gel electrophoresis,
difference in PCR product length was found between the cells
transfected with wild type and mutant DSPP alleles. The product
of wild type was 186bp in length, while the mutant had a main
product of 319bp (Figure 4) indicating the non-splicing of intron 3.
The products were further confirmed by sequencing from both
strands. The in vitro splicing analysis was replicated by transfecting
the plasmids into COS-1 cells. PCR result was the same as that in
293T cells (Figure 4). Thus, the splicing alteration of this mutation
(non-splicing of intron 3) was proved. Taken together with the
information from the family tree, this autosomal dominant splicing
mutation g.8662T.C was indicated to be the causation of DGI-II
in this pedigree.
Splicing alteration is an important disease-causing mechanism.
It is reported that approximately 15% of human genetic diseases
are caused by mutations at or near splice sites [9]. Previous studies
have revealed several mutations (g.8658C.T [10,11],
g.8661G.A [12], g.8661G.T [5] and g.8663A.G [13]) in or
adjacent to this splice donor site to be the causation of DGI-II.
However, the function was not confirmed in any of these
mutations. Instead, a skip of exon 3 (p.V18_Q45del) was
hypothesized. In this study, we identified the novel causative
mutation g.8662T.C in this site and for the first time confirmed
its function, which was the non-splicing of intron 3. Before that, as
to the function of DSPP mutations, only a skip of exon 3 was
noticed by in vitro splicing analysis in another DSPP mutation [1].
Our results indicated that splicing was of key importance to the
function of DSPP and that this splice donor site might be a
sensitive mutation hot spot of DGI-II (another ‘‘hot spot’’ was
reported as g.6191G.T (c.52G.T) [11,12,14]).
Genetic testing is a new method helping to predict, screen and
diagnose diseases. Our results, combined with other reported data
[5] offered DSPP single nucleotide mutations as well as the
mechanism in DGI pedigrees. The findings would facilitate the
genetic diagnosis of DGI through genetic testing, shed light on its
gene therapy and help to finally conquer human diseases.
In conclusion, we identified a novel mutation in the splice donor
site of DSPP (g.8662T.C), for the first time proved its function in
altering gene transcription (non-splicing of intron 3), and
concluded it to be the causation of DGI type II in a Chinese
Han pedigree.
Materials and Methods
Ethics Statement
This study was approved by the Human Research Review
Committee of Huashan Hospital, Fudan University. All partici-
pants signed the informed consent forms and all investigations
were carried out adhered to the principles in the Declaration of
Helsinki.
Subjects
The pedigree was taken notice of in our clinical work. Five
generations were included and three generations are living (III to
V). 38 family members were visited (III1,III15,I V 1,IV16,
V1,V8) and 26 DGI-II affected members were discovered (I1,
II1,I I 2,I I 3, III4, III5, III6, III7, III11, III12, III15,I V 2,I V 4,I V 5,
IV6,I V 7,I V 8,I V 9,I V 12,I V 13,I V 15,I V 16,V 2,V 4,V 7,V 8,
consisting of 15 males and 11 females). 5-10mL of peripheral
blood sample from each of 20 family members was collected (III4,
III6, III11, III15,I V 1,I V 2,I V 3,I V 6,I V 7,I V 8,I V 9,I V 12,I V 15,
IV16,V 1,V 2,V 4,V 6,V 7,V 8, consisting of 16 affected and four
unaffected members). DNAs were then extracted by QIAamp
DNA Blood Mini Kit (QIAGEN, Hilden, Germany). At the same
time, 105 unrelated healthy subjects were recruited as genomic
controls to evaluate the revealed mutations.
Sequence analysis
The genomic regions of interest were amplified by PCR and
subsequently analyzed by double strand sequencing to detect the
mutations. The PCR and sequencing were performed with the
following primers:
DSPP-11F: AGTGCTGAGCCTGGTGATG
DSPP-11R: CACAGATATCACATAAAGCCC
DSPP-NEW3F: CAAGCCCTGTAAGAAGCCACT
DSPP-NEW3R: TGCTTCCAGCTACTTGAGGTC
The sequencing raw data revealing the novel g.8662T.C
mutation was deposited in GenBank (accession number:
JN625214). The following primers were used to confirm the
mutation in affected and unaffected subjects from the pedigree as
well as in the other 105 unrelated healthy controls:
PCR primers: DSPP1933_L: TCTGGTCACGCCTCCTG-
TTC, DSPP1933_R: GCATCCTGGTGCTTAGATTCCTT
Sequencing primers: F. Re-seq.:TTGGCAGGTTCCTCAA-
AGCA, DSPP319_R: TTCCCTCCTACTTCTGCCCAC
The sequencing raw data were read by the software Mutation
Surveyor v3.24 (SoftGenetics, State College, United States) to
reveal the variations.
The online splicing adaptor prediction was carried out by
SplicePort (http://spliceport.cs.umd.edu). Both wild type and
g.8662T.C substituted whole DSPP gene sequences were
inputted and the prediction was performed using default settings.
In vitro splicing analysis
The 1933bp DSPP allele containing whole exon3-intron3-
exon4 and partial intron 2 and intron 4 was amplified by PCR
with the following primers: DSPP1933_L_MunI: CCCCAATT-
GTCTGGTCACGCCTCCTGTTC and DSPP1933_R_XhoI:
Figure 4. PCR products of DSPP alleles in splicing vector pLRT
transfected into 293T and COS-1 cells. From left to right: D2000
marker, 293T cell control, naı ¨ve pLRT, mutant DSPP allele and wild type
DSPP allele in 293T cells, D2000 marker, COS-1 cell control, naı ¨ve pLRT,
mutant DSPP allele and wild type DSPP allele in COS-1 cells.
doi:10.1371/journal.pone.0027982.g004
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cloned into the EcoR I/Xho I sites of pLRT to construct the
recombinant plasmid. The plasmid was transformed into Esche-
richia coli strain DH5a to amplify and was subsequently extracted
for further use.
Human Embryonic Kidney cell line 293T and African green
monkey kidney fibroblast-like cell line COS-1 (Cell Resource
Center of Shanghai Institutes for Biological Sciences, Chinese
Academy of Sciences, Shanghai, China) were used in cell
transfection. Twenty-four hours before transfection, 1.0610
5 cells
were plated in each well of a 12-well plate. By adding 3 mL
Lipofectamine 2000 (Invitrogen, Carlsbad, United States), 0.6 mg
testing plasmid was transfected into the cells according to the
manual of Lipofectamine 2000. The medium was changed to full
Dulbecco’s Modified Eagle Medium with high glucose (DMEM-h,
Invitrogen) after four hours and the cells were harvested after 24
hours. Total RNAs of the cells were extracted by TRI reagent
(Sigma-Aldrich, St. Louis, United States) according to the
manufacturer’s manual. Reverse transcription were carried out
using High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, United States). cDNAs were then tested
by PCR with the following primers: DSPP319_L: AAAATC-
CATGAATTTGCATCTCC and DSPP319_R: TTCCCTCC-
TACTTCTGCCCAC. The PCR product was evaluated by gel
electrophoresis and confirmed by sequencing with the same
primers.
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